The development of radiotherapy, image technology and chemotherapy prolongs the survival of patients with nasopharyngeal carcinoma: a cohort study with 20305 patients from 1990 to 2012

This study explored the survival trends and treatment failure patterns of patients with non-metastatic nasopharyngeal carcinoma (NPC) treated with radiotherapy. Furthermore, we evaluated the survival benefit brought by the development of radiotherapy, image technology and chemotherapy based on a large cohort from 1990 to 2012.

Source: International Journal of Radiation Oncology * Biology * Physics - July 14, 2019 Category: Radiology Authors: Xue-Song Sun, Sai-Lan Liu, Mei-Juan Luo, Xiao-Yun Li, Qiu-Yan Chen, Shan-Shan Guo, Yue-Feng Wen, Li-Ting Liu, Hao-Jun Xie, Qing-Nan Tang, Yu-Jing Liang, Jin-Jie Yan, Da-Feng Lin, Ming-min Bi, Ying Liu, Yu-fan Liang, Jun Ma, Lin-Quan Tang, Hai-Qiang Mai Source Type: research